Matches in Nanopublications for { ?s ?p "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP401650.RAZH3WE1FLviI4jtdNQJ5ivoE6KpIwB2WSssJg7cUasjA130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401650.RAZH3WE1FLviI4jtdNQJ5ivoE6KpIwB2WSssJg7cUasjA130_provenance.
- NP401658.RAUU_GCzOUNB4HnOYR8-dQbgiDH18ggZ68z0SFKdSPljk130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401658.RAUU_GCzOUNB4HnOYR8-dQbgiDH18ggZ68z0SFKdSPljk130_provenance.
- NP482002.RAXnXACZlCscmNgXoXd_kfZjWBB8uS5UMgbLNh644XtF4130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482002.RAXnXACZlCscmNgXoXd_kfZjWBB8uS5UMgbLNh644XtF4130_provenance.
- assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1042820.RAaUNyS0Oytuiif0sCmkD64KRK3U7ycvreXl3cu0RuC-o130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042820.RAaUNyS0Oytuiif0sCmkD64KRK3U7ycvreXl3cu0RuC-o130_provenance.
- NP1042808.RABQKD800QiQQsf0ZV-oYGMt_EnvLuFVPMk0EotKIUPao130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042808.RABQKD800QiQQsf0ZV-oYGMt_EnvLuFVPMk0EotKIUPao130_provenance.
- NP481977.RAr-nzQ4c7Md85Rr_TQEzvHLo4d1KOfvBueXxQzPpZWyg130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481977.RAr-nzQ4c7Md85Rr_TQEzvHLo4d1KOfvBueXxQzPpZWyg130_provenance.
- NP1042813.RAlS5x2f-CUO2IFqLvfmPYjy9iBKYxfYwLHzxwMYJmfVs130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042813.RAlS5x2f-CUO2IFqLvfmPYjy9iBKYxfYwLHzxwMYJmfVs130_provenance.
- NP1042818.RAh0-qXR283r3pLoBf8Zmp7wBoy7ZOqcX7NPkUJRGccmc130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042818.RAh0-qXR283r3pLoBf8Zmp7wBoy7ZOqcX7NPkUJRGccmc130_provenance.
- NP401425.RAPHN8Vl437FIlk_iGy8YuS38HRHqBLO809TLTWSMf73s130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401425.RAPHN8Vl437FIlk_iGy8YuS38HRHqBLO809TLTWSMf73s130_provenance.
- NP401663.RAFpnvzqoO3y32gAWclP-b9NjhDJtTe9QoOnEL0onLBB4130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401663.RAFpnvzqoO3y32gAWclP-b9NjhDJtTe9QoOnEL0onLBB4130_provenance.
- NP1042804.RAKJkgbUTXmrmtj0i_1ahiabqxGNn2WjduS1wySYgVJw4130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042804.RAKJkgbUTXmrmtj0i_1ahiabqxGNn2WjduS1wySYgVJw4130_provenance.
- NP1042815.RAMKCeiwSmpAbryzadtCkThNz9flh7TcngGUXFSssGvjw130_assertion description "[Compared to female breast cancer, IGF1-R and carbonic anhydrase 12 (CAXII) were more frequently and CD44v6, MET and FGFR2 less frequently expressed in male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042815.RAMKCeiwSmpAbryzadtCkThNz9flh7TcngGUXFSssGvjw130_provenance.